Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Concordia University

$20,000.00

Multidimensional Separation Tools for Proteomics and Methods to Determine Metabolic Capacity

FY 2018-19

Summary
Proteins, the veritable building blocks of life, perform a multitude of functions and are the most important and diverse biological species in the body. There are tens of thousands of different proteins, each performing its specialized function while being held in careful balance in a healthy person. In response to stress, drugs, infection, puberty, disease, injury, pregnancy and other events in life, the body alters the types and concentrations of proteins to better perform specific tasks. Clearly, identifying and measuring all these proteins is critical to advancing our understanding of how proteins, and their interactions, drive the life process. To answer fundamental questions of biochemistry, we need analytical tools that can directly measure and characterize proteins from complex biological samples. This proposal has two main avenues of research. In the first, we propose building a multidimensional separation system capable of resolving and measuring thousands of proteins. Compared to current systems that can only resolve hundreds of proteins, this will be a huge step forward. We will use this system to map the proteins present in diverse biological samples such as urine, amniotic fluid and serum. Hand-in-hand with the separation system we will develop an instrument that will allow us to select specific proteins from the map and break them down into their component peptides for identification.*The second avenue of research in this proposal is to develop proteomic strategies to quantitate liver-localized cytochrome P450 enzymes in forensic samples. These enzymes are responsible for breaking-down drugs in the body. In cases of drug toxicity/overdose forensic toxicologists need to be able to measure the concentration of these key enzymes. Were they critically low and allowed the drug to build-up to toxic levels? Are they too high and converted a beneficial pharmaceutical into a toxic by-product faster than the body could clear it? Does the victim have a genetic fault that makes them vulnerable to drug toxicity? Having the tools to answer these questions is challenging because, at death, the liver tissue begins to breakdown and microbes invade the liver. We will determine the postmortem window in which these enzymes can be determined, develop a quantitative method to measure them, determine if the victim had unusual genetic mutations and ultimately classify the victim's metabolic capacity. With these pieces of information, the forensic toxicologist can determine the role of drugs in the death.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-06235
Name nom
Skinner, Cameron
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2015
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3503
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Separation methods
Research subject fr
Méthodes de séparation
Partie
4
Nb partie
5
Application title
Multidimensional Separation Tools for Proteomics and Methods to Determine Metabolic Capacity
Keyword
NSERC
Application summary
Proteins, the veritable building blocks of life, perform a multitude of functions and are the most important and diverse biological species in the body. There are tens of thousands of different proteins, each performing its specialized function while being held in careful balance in a healthy person. In response to stress, drugs, infection, puberty, disease, injury, pregnancy and other events in life, the body alters the types and concentrations of proteins to better perform specific tasks. Clearly, identifying and measuring all these proteins is critical to advancing our understanding of how proteins, and their interactions, drive the life process. To answer fundamental questions of biochemistry, we need analytical tools that can directly measure and characterize proteins from complex biological samples. This proposal has two main avenues of research. In the first, we propose building a multidimensional separation system capable of resolving and measuring thousands of proteins. Compared to current systems that can only resolve hundreds of proteins, this will be a huge step forward. We will use this system to map the proteins present in diverse biological samples such as urine, amniotic fluid and serum. Hand-in-hand with the separation system we will develop an instrument that will allow us to select specific proteins from the map and break them down into their component peptides for identification.*The second avenue of research in this proposal is to develop proteomic strategies to quantitate liver-localized cytochrome P450 enzymes in forensic samples. These enzymes are responsible for breaking-down drugs in the body. In cases of drug toxicity/overdose forensic toxicologists need to be able to measure the concentration of these key enzymes. Were they critically low and allowed the drug to build-up to toxic levels? Are they too high and converted a beneficial pharmaceutical into a toxic by-product faster than the body could clear it? Does the victim have a genetic fault that makes them vulnerable to drug toxicity? Having the tools to answer these questions is challenging because, at death, the liver tissue begins to breakdown and microbes invade the liver. We will determine the postmortem window in which these enzymes can be determined, develop a quantitative method to measure them, determine if the victim had unusual genetic mutations and ultimately classify the victim's metabolic capacity. With these pieces of information, the forensic toxicologist can determine the role of drugs in the death.
Concordia University - $20,000 Grant (2018-19) | Canada Spends